Sign Up Today and Learn More About PatientsLikeMe Stock
Invest in or calculate the value of your shares in PatientsLikeMe or other pre-IPO companies through EquityZen's platform.
About PatientsLikeMe Stock
Founded
2004
Headquarters
Cambridge, MA, US
Total Funding
127M
Industries
Software, Artificial Intelligence, Data and Analytics
PatientsLikeMe, the world’s largest personalized health network, helps people find new options for treatments, connect with others, and take action to improve their outcomes. The company has worked with every major pharmaceutical company and a range of government organizations to bring the patient voice to research, development and public policy. With more than 500,000 members, PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 100 research studies.
PatientsLikeMe Press Mentions
Stay in the know about the latest news on PatientsLikeMe
PatientsLikeMe Names Greg Ploussios Senior Vice President and General Counsel
Business Wire (press release) • Aug 02, 2017
PatientsLikeMe Poll Reveals Must-Haves for Health Care Law
Business Wire (press release) • Jun 14, 2017
PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases
Business Wire (press release) • Apr 10, 2017
PatientsLikeMe Nabs $100M, Works to Advance Personalized Medicine
Xconomy • Jan 06, 2017
Investors in PatientsLikeMe
Discover investors in PatientsLikeMe stock and explore their portfolio companies
PatientsLikeMe Management
Leadership team at PatientsLikeMe
VP of Innovation
Paul Wicks
Co Founder & Chairman
James Heywood
Join now and verify your accreditation status to gain access to:
- PatientsLikeMe current valuation
- PatientsLikeMe stock price
- Available deals in PatientsLikeMe and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in PatientsLikeMe stock?
Accredited investors can buy pre-IPO stock in companies like PatientsLikeMe through EquityZen funds. These investments are made available by existing PatientsLikeMe shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PatientsLikeMe stock?
Shareholders can sell their PatientsLikeMe stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
